Bioceltix S.A. (BCX.WA)
Bioceltix S.A.
80.30-0.18%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-21.9%
The outlook
Bioceltix S.A. currently reads as neutral based on strong buy — 1.0 avg of 1 analysts, below its 50- & 200-day averages, 27% of the way from its 52-week low to high, avg target +66% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendBelow its 50- & 200-day averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +66% vs current price
Market cap
$444.2M
52-wk high
108.00
52-wk low
70.00
50-day avg
89.42
200-day avg
85.99
Trailing P/E
—